DK142145B - Modificeret opiumsalkaloidantigen til anvendelse ved fremstilling af et antistof til brug ved påvisning af tilstedeværelsen af et opiumsalkaloid i en biologisk væske. - Google Patents
Modificeret opiumsalkaloidantigen til anvendelse ved fremstilling af et antistof til brug ved påvisning af tilstedeværelsen af et opiumsalkaloid i en biologisk væske. Download PDFInfo
- Publication number
- DK142145B DK142145B DK228271AA DK228271A DK142145B DK 142145 B DK142145 B DK 142145B DK 228271A A DK228271A A DK 228271AA DK 228271 A DK228271 A DK 228271A DK 142145 B DK142145 B DK 142145B
- Authority
- DK
- Denmark
- Prior art keywords
- antigen
- opium alkaloid
- antibody
- protein
- alkaloid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/643—Albumins, e.g. HSA, BSA, ovalbumin or a Keyhole Limpet Hemocyanin [KHL]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK443373A DK142146B (da) | 1970-05-13 | 1973-08-10 | Opiumsalkaloid-specifikt antistof til brug ved påvisning af et opiumsalkaloid i en biologisk væske. |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3699970A | 1970-05-13 | 1970-05-13 | |
| US3699970 | 1970-05-13 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK142145B true DK142145B (da) | 1980-09-08 |
| DK142145C DK142145C (index.php) | 1981-02-02 |
Family
ID=21891894
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK228271AA DK142145B (da) | 1970-05-13 | 1971-05-12 | Modificeret opiumsalkaloidantigen til anvendelse ved fremstilling af et antistof til brug ved påvisning af tilstedeværelsen af et opiumsalkaloid i en biologisk væske. |
Country Status (5)
| Country | Link |
|---|---|
| CA (1) | CA966778A (index.php) |
| DE (1) | DE2166716C3 (index.php) |
| DK (1) | DK142145B (index.php) |
| GB (1) | GB1320056A (index.php) |
| SE (4) | SE389739B (index.php) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4104367A (en) * | 1976-10-13 | 1978-08-01 | Hoffmann-La Roche Inc. | Radioimmunoassay for methadone |
| CN113968853B (zh) * | 2020-07-22 | 2022-09-16 | 中国农业大学 | 阿托品类生物碱的半抗原、人工抗原及其制备方法与应用 |
-
1971
- 1971-05-11 DE DE2166716A patent/DE2166716C3/de not_active Expired
- 1971-05-12 CA CA112,764A patent/CA966778A/en not_active Expired
- 1971-05-12 DK DK228271AA patent/DK142145B/da unknown
- 1971-05-13 SE SE7408141A patent/SE389739B/xx not_active IP Right Cessation
- 1971-05-13 SE SE7106271A patent/SE389737B/xx unknown
- 1971-05-13 GB GB1462971*[A patent/GB1320056A/en not_active Expired
-
1974
- 1974-06-19 SE SE7408141A patent/SE7408141L/xx unknown
- 1974-06-19 SE SE7408140A patent/SE417970B/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| SE7408140L (index.php) | 1974-06-19 |
| DE2123300A1 (de) | 1971-11-25 |
| DE2166716A1 (de) | 1975-04-24 |
| CA966778A (en) | 1975-04-29 |
| DE2123300B2 (de) | 1976-03-04 |
| SE389739B (sv) | 1976-11-15 |
| DE2166716C3 (de) | 1980-06-12 |
| SE7408141L (index.php) | 1974-06-19 |
| DE2166716B2 (de) | 1979-09-27 |
| SE389737B (sv) | 1976-11-15 |
| DK142145C (index.php) | 1981-02-02 |
| SE417970B (sv) | 1981-04-27 |
| GB1320056A (en) | 1973-06-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3709868A (en) | Opium alkaloid antigens and antibodies specific therefor | |
| Ranadive et al. | Antibodies to serotonin | |
| US3766162A (en) | Barbituric acid antigens and antibodies specific therefor | |
| JP6667472B2 (ja) | リスペリドン及びパリペリドンのハプテン | |
| DK157340B (da) | Fremgangsmaade til fremstilling af et pancreatisk glucagonspecifikt antistof | |
| US3704282A (en) | Catecholamine antigens and antibodies specific therefor | |
| US7195882B2 (en) | Monoclonal antibodies specific for buprenorphine and metabolites thereof | |
| US4078049A (en) | Acetylcholine assay | |
| JPS6057254A (ja) | 免疫学的測定法による糖脂質の定量方法 | |
| DK142145B (da) | Modificeret opiumsalkaloidantigen til anvendelse ved fremstilling af et antistof til brug ved påvisning af tilstedeværelsen af et opiumsalkaloid i en biologisk væske. | |
| CN112250641A (zh) | 双氢克尿噻半抗原、人工抗原、抗体及其制备方法和应用 | |
| US3809782A (en) | Tubocurarine antigens and antibodies specific therefor | |
| EP1470825A1 (en) | Reagents for detecting efavirenz | |
| JPS61130263A (ja) | 二官能性ハプテンおよび免疫化学的ハプテン測定法 | |
| US4107157A (en) | Barbituric acid antigens and antibodies specific therefor | |
| US6814951B1 (en) | Acetaldehyde and malondialdehyde protein adducts as markers for alcohol liver disease | |
| JPS5888660A (ja) | ヨードチロニン免疫複合体に対する抗体 | |
| US20060240496A1 (en) | Immunogens, derivatives and immunoassay for ethyl glucuronide | |
| JP3601972B2 (ja) | 色素標識タンパク質複合体およびその製造方法 | |
| US4094964A (en) | Clonidine assay | |
| EP0016594B1 (en) | Steroidal phosphonothioate compounds, process for preparing them, compositions containing said compounds, process for preparing said compositions, method of producing an antiserum and method of radioimmunoassay | |
| JPS607362A (ja) | 酵素を用いた抗原決定基具有物質の測定法 | |
| WO1997015324A1 (en) | High fluorescence specific immune enhancing factor and methods of use for same | |
| DK142146B (da) | Opiumsalkaloid-specifikt antistof til brug ved påvisning af et opiumsalkaloid i en biologisk væske. | |
| CN108178793A (zh) | 一种用于偶联sncg、lp-pla2和11-脱氢血栓烷增强免疫的载体蛋白制备方法 |